RPG Life Sciences hosts analyst meet on September 2 in Mumbai
- RPG Life Sciences hosts analyst/investor meet on September 2, 2026
- Event scheduled for 10:00 am IST in Mumbai
- Part of Ashwamedh – Elara India Dialogue 2026
- Format includes group and one-on-one physical sessions

*this image is generated using AI for illustrative purposes only.
RPG Life Sciences Limited will host an analyst and institutional investor meeting on September 2, 2026, at 10:00 am IST. The event is scheduled as part of the Ashwamedh – Elara India Dialogue 2026 in Mumbai.
Meeting details
The company disclosed the engagement pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The meeting will be held in a physical format in Mumbai, featuring both group and one-on-one sessions.
| Event detail | Information |
|---|---|
| Event type | Analyst/Institutional Investors meet |
| Scheduled date | September 2, 2026 |
| Time | 10:00 am onwards |
| Venue/Mode | Mumbai / Physical |
| Host | Ashwamedh – Elara India Dialogue 2026 |
| Nature | Group Meet/one-on-one |
Rajesh Shirambekar, Head-Legal & Company Secretary, confirmed the details. The date remains subject to change due to exigencies on the part of the company or host. Any presentation made during the meet will align with the presentation available on the company’s website and stock exchange portals.
Historical Stock Returns for RPG Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.48% | -5.72% | -12.00% | +37.31% | +10.11% | +423.92% |
What specific strategic updates or financial guidance is RPG Life Sciences expected to present to investors during the Ashwamedh – Elara India Dialogue?
How might the outcomes of this institutional investor meeting influence RPG Life Sciences' stock valuation in the short term following September 2, 2026?
Are there any pending regulatory approvals or clinical trial milestones for RPG Life Sciences that are likely to be a focal point of discussion at this event?


































